MDMA: What Went Wrong Part 1

Online clinics delivered at-home ketamine throughout the pandemic, and we’re just becoming aware of the consequences. Publication Date: 2/27/2023Duration: 19 mins, 15 secondsChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any ...  Show more

Learn how clinicians can enhance their patient’s quality of life by improving sleep outcomes.Published On: 02/20/2023Duration: 18 minutes, 48 seconds 

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ...  Show more

In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ...  Show more

In this episode, I discuss Methyl​enedioxy​methamphetamine (MDMA), which is also commonly known as “ecstasy” or “molly,” including how it works in the brain to cause short- and long- term-shifts in emotional processing and its clinical applications for the treatment of post-traum ...  Show more

“Whatever is emerging, we want to help people explore it and experience it,” says Rick Doblin. GP interviewed the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) about the impact MDMA-assisted psychotherapy may have on PTSD, eati ...  Show more